NCT00005027View on ClinicalTrials.gov

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Kidney Cancer
Interventions
DRUG

becatecarin

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER